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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S141narrowing (JSN) were assessed using OARSI atlas. T1- or T2-weighted
fat suppressed magnetic resonance imaging (MRI) was utilized to
infrapatellar fat pad maximum area, cartilage volume, cartilage defect
and bone marrow lesions (BMLs). Knee pain was assessed by self-
administered Western Ontario McMaster Osteoarthritis Index
(WOMAC) questionnaire.
Results: Infrapatellar fat pad maximum area was positively associated
with age, height, weight, and negatively with female sex (all p<0.01 in
multivariable analyses). After adjustments of age, sex, height, weight,
disease status and/or knee radiographic features, infrapatellar fat pad
maximum area was signiﬁcantly associated with decreased joint space
narrowing (OR: 0.74 to 0.78, p<0.02) and osteophytes (OR: 0.52,
p<0.01), increased knee tibial and patellar cartilage volume (beta: 59 to
165 mm3/cm2, all P<0.001), decreased tibial cartilage defects (OR: 0.54
to 0.58, all p<0.01), decreased BMLs (OR: 0.77, p<0.01), and decreased
knee pain (pain on ﬂat surface, OR: 0.79, P<0.05; pain on stairs, OR:
0.84, p¼0.06). Longitudinally, infrapatellar fat pad maximum area was
signiﬁcantly associated with less loss of cartilage volume (medial tibial,
beta: 0.8% per cm2, p¼0.01; lateral tibial, beta: 0.7% per cm2, p¼0.019),
and less increase in cartilage defects (medial tibiofemoral, OR: 0.65,
p¼0.003).
Conclusions: Infrapatellar fat pad maximum area is associated with
decreased knee pain, radiographic OA, BMLs, and less cartilage loss and
defect progression/development, suggesting that infrapatellar fat pad
may be protective against knee OA in older adults.
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COMPARISON OF COMPLICATION RATES FOLLOWING TOTAL HIP
ARTHROPLASTY IN INDIVIDUALS WITH RA VERSUS OA
B. Ravi y, R. Croxford z, S. Hollands z, G.A. Hawker y. yUniv. of Toronto,
Toronto, ON, Canada; z Inst. of Clinical Evaluative Sci. (ICES), Toronto,
ON, Canada
Purpose:Much of the literature on predictors of outcomes and rates of
complications following total hip arthroplasty (THA) has focused on the
experience in patients with osteoarthritis (OA). However, THA is also
used to treat patients with rheumatoid arthritis (RA), a fundamentally
different condition in terms of pathogenesis, prognosis and medical
management. Studies that have examined outcomes following THA in
patients with RA have been limited by the use of variable deﬁnitions for
RA, many of which have not been validated. Thus, the risk for
misclassiﬁcation bias, with crossover between RA, OA and other
inﬂammatory arthritides (IA) is potentially high, raising questions about
the validity of ﬁndings. We took advantage of a recently validated
algorithm for RA using administrative data, with a high speciﬁcity and
positive predictive value, to determine the prevalence of RA amongst
THA recipients, and to compare of complications rates of THA in
patients with RA versus OA.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA between 2002-2009 utilizing administrative
databases from Ontario, Canada. We excluded those who received
a primary or revision arthroplasty of the hip or knee prior to April 1,
2002, those whose ﬁrst procedure was non-elective (e.g. for cancer,
fracture, or injury), or those with a history of hip dysplasia. RA was
deﬁned using the following validated algorithm: a hospitalization for
RA, or 3 physician RA OHIP claims with at least 1 claim by a specialist
[rheumatologist, orthopedic surgeon or internist] in a 2y period).
Recipients with diagnostic codes suggesting IA (e.g., psoriatic arthritis,
lupus, etc) or with a code for RA but who did not meet criteria were
classiﬁed as having IA. All remaining patients were deemed to have OA.
We compared baseline characteristics and rates of complications
following the index THA for recipients with RA versus OA. Generalized
estimating equations were used to determine the relationship between
arthritis type and the occurrence of speciﬁc complications (within 90d:
DVT/PE, mortality; within 2y: dislocation, infection, peri-prosthetic
fracture and revision), deﬁned using validated algorithms, controlling
for potential confounders (income quintile, rurality, and provider
volume) and for clustering by surgeons.
Results: Between April 1, 2002 and March 31, 2009, there were 43,997
patients who received their ﬁrst THA (OA: 37,881 - 86%; IA: 4,953 - 11%;
RA: 1,163 - 3%). Compared with THA recipients who had OA, those with
RA were more likely to be female (73.5% versus 53.9%, p<0.0001), were
younger (mean age 62.4y vs 66.3y, p<0.0001), and had greater co-
morbidity (Charlson score of 2+: 9.8% vs 4.4%, p<0.0001). Controlling
for these differences, and other potential confounders, THA recipientswith RA were more likely to experience hip dislocation (adjusted OR
1.92, 95%CI 1.27, 2.89, p<0.0001) and less likely to experience DVT/PE
(adjusted OR 0.32, 95%CI 0.14, 0.76, p¼0.007), but were similarly likely
to experience all other complications: infection (adjusted OR 1.07, 95%CI
0.59, 1.92), early revision (adjusted OR 1.39, 95%CI 0.81, 2.41), peri-
prosthetic fracture (adjusted OR 1.22, 95%CI 0.56, 2.66) and death
within 90d (adjusted OR 1.86, 95%CI 0.96, 3.60).
Conclusions: In a population cohort undergoing their ﬁrst primary
THA, w3% of recipients had a diagnosis of RA. These patients were at
increased risk of dislocation within 2years of their surgery, at lower risk
for DVT/PE, and at similar risk for infection, fracture, death or early
revision following THA. To our knowledge, this is the ﬁrst study that has
utilized a validated algorithm to identify THA recipients with RA,
thereby increasing the validity of our ﬁndings, and aiding patient-
physician decision-making around joint replacement in patients with
RA. Further research is required to elucidate potential explanations for
the higher rates of dislocation following THA in RA versus OA.
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COMPARISON OF COMPLICATION RATES FOLLOWING TOTAL KNEE
ARTHROPLASTY IN INDIVIDUALS WITH RA VERSUS OA
B. Ravi y, R. Croxford z, S. Hollands z, G.A. Hawker y. yUniv. of Toronto,
Toronto, ON, Canada; z Inst. of Clinical Evaluative Sci. (ICES), Toronto,
ON, Canada
Purpose:Much of the literature on predictors of outcomes and rates of
complications following total knee arthroplasty (TKA) has focused on
the experience in patients with osteoarthritis (OA). However, TKA is also
used to treat patients with rheumatoid arthritis (RA), a condition that
fundamentally differs from OA in terms of pathogenesis, prognosis and
medical management. Studies that have examined outcomes following
TKA in patients with RA have been limited by the use of variable deﬁ-
nitions for RA, many of which have not been validated. Thus, the risk for
misclassiﬁcation bias, with crossover between RA, OA and other
inﬂammatory arthritides (IA) is potentially high, raising questions about
the validity of ﬁndings. We took advantage of a recently validated
algorithm for RA using administrative data, which has been shown to
have a high speciﬁcity and positive predictive value, to determine the
prevalence of RA amongst TKA recipients, and to compare of compli-
cations rates of TKA in patients with RA versus OA.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective TKA between 2002-2009 utilizing health administra-
tive data from Ontario, Canada. We excluded those who had received
a primary or revision arthroplasty of the hip or knee prior to April 1,
2002, and those whose ﬁrst procedure was non-elective (e.g. for cancer,
fracture, or external cause of injury). RAwas deﬁned using the following
validated algorithm: a hospitalization for RA (ICD-10 code 714), or 3
physician RA OHIP claims with at least 1 claim by a specialist [rheu-
matologist, orthopedic surgeon or internist] in a 2 year period). TKA
recipients with diagnostic codes suggesting IA (e.g., diagnostic code for
psoriatic arthritis, lupus, etc) or with a code for RA but who did not
meet criteria for RA were classiﬁed as having IA. All remaining patients
were deemed to have OA. We compared baseline characteristics and
rates of complications following the index TKA for recipients with RA
versus OA. Generalized estimating equations were used to determine
the relationship between arthritis type and the occurrence of speciﬁc
complications (within 90d: DVT/PE, mortality; within 2y: infection and
revision), deﬁned using validated algorithms, controlling for potential
confounders (income quintile, rurality, prior intra-articular injection,
and provider volume) and for clustering by surgeons.
Results: Between April 1, 2002 and March 31, 2009, there were 71,793
patients who received their ﬁrst TKA (OA: 59,564 - 83%; IA: 9,537 - 13%;
RA: 2,692 - 4%). TKA recipients with RA were more likely to be female
(75.5% versus 60.6%, p<0.0001), younger (mean age 65.4y versus 67.7y,
p<0.0001), and had greater co-morbidity (Charlson score of 2+: 7.4%
versus 4.3%, p<0.0001). Controlling for these differences, and for other
potential confounders, TKA recipients with RA were more likely than
those with OA to experience infection (adjusted OR 1.52, 95%CI 1.09,
2.10, p¼0.007), but did not differ signiﬁcantly with respect to likelihood
for experiencing: DVT/PE (adjusted OR 0.76, 95%CI 0.53, 1.08), early
revision (adjusted OR 0.84, 95%CI 0.57, 1.23), and death within 90d
(adjusted OR 1.08, 95%CI 0.61, 1.93).
Conclusions: In a population inception cohort undergoing their ﬁrst
primary TKA,w4% of recipients had a diagnosis of RA. Compared with
TKA recipients with OA, those with RA were more likely to experience
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S142infection within 2years of their surgery, but did not differ in terms of
risk for DVT/PE, early revision, infection, peri-prosthetic fracture or
death following TKA. To our knowledge, this is the ﬁrst study that has
utilized a validated algorithm to identify TKA recipients with RA,
thereby increasing the validity of our ﬁndings, and aiding patient-
physician decision-making around joint replacement in patients with
RA. Further research is required to elucidate potential explanations for
the higher rates of infection in RA versus OA, including the use of bio-
logic agents.
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MORE PROMINENT INFLAMMATORY FEATURES IN KNEE
OSTEOARTHRITIS IN THE PRESENCE OF CONCOMITANT HAND
OSTEOARTHRITIS
C. Orellana, N. Navarro, J. Calvet, M. García-Manrique, J. Gratacós,
M. Larrosa. CSiU Parc Taulí. Hosp. de Sabadell, Sabadell, Spain
Background: In recent years it has been recognized the existence of
a link between hand osteoarthritis and systemic inﬂammation. On the
other hand, a signiﬁcant proportion of patients with knee osteoarthritis
show local clinically evident inﬂammatory features such as synovial
effusion and synovial hypertrophy.
Purpose: To evaluate if patients with knee osteoarthritis show more
inﬂammatory signs as measured by ultrasound when hand osteoar-
thritis is concomitantly present.
Methods: Patients aged 50 years or more with symptomatic osteoar-
thritis of the knee and joint effusion, Kellgren-Lawrence II-III. Demo-
graphics, BMI, disease duration, pain assessed by VAS (0-100 mm) and
algofuncional Lequesne index were assessed. Knee ultrasound was
performed evaluating and measuring the presence of effusion and
synovial hypertrophy (deﬁned as > 4 mm synovial thickening) at the
suprapatellar midline.
Results: In a cross-sectional study we analyzed 50 patients, F/M 39/11,
age 61.8 10.1 years, disease duration 50.8 6.3 months, BMI 28 1.4
kg/cm2. Ten patients (20%) had concomitant hand osteoarthritis. There
were no signiﬁcant differences in age, disease duration, BMI or radio-
logical grade between patients with knee and hand osteoarthritis
compared with those with only knee osteoarthritis. On ultrasound
examination patients with concomitant hand osteoarthritis showed
a clear trend to have a more prominent joint effusion (7.39  3 vs. 6.7
2.8 mm) and synovial hypertrophy (3.6  2.6 vs. 2.7 1.8 mm),
although not statistically differences were found. Patients with
concomitant hand osteoarthritis also had a non-signiﬁcant trend to
experience greater knee pain (VAS 70.3 12.5 vs. 61 18.5 mm) and
Lesquesne index scores (11.4 3.3 vs. 9.8 2.9).
Conclusions: Although results were not statistically signiﬁcant prob-
ably in relation to small size sample, in this study the presence of hand
osteoarthritis appeared to be associated with greater inﬂammatory
features in patients with symptomatic knee osteoarthritis.
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NETWORKING TO CAPTURE PATIENT-REPORTED OUTCOMES
DURING ROUTINE ORTHOPAEDIC CARE ACROSS TWO DISTINCT
INSTITUTIONS
R. Karia y, J. Slover y, C. Hauer z, Z. Gelber y, P. Band y, J. Graham z. yNew
York Univ. Sch. of Med., NY, USA; zGeisinger Med. Systems, Danville, PA,
USA
Purpose: Osteoarthritis of the knee is a chronic disease associated with
pain and reduced quality of life, and the ability to reliably measure
patient-reported symptoms is important for clinical decision-making
and as a tool for future clinical research. A large number of validated
questionnaires for this purpose have been developed, but they are
typically restricted to use in research studies because of the logistical
barriers to integrating paper-based questionnaires into routine clinic
workﬂow. Electronic and web-based tools can eliminate much of the
labor-intensive aspects of questionnaire administration and enable
real-time evaluation of responses by physicians and integration of data
frommultiple sites for research purposes. The purpose of this study was
to evaluate the implementation of a single integrated electronic
outcome measurement system into routine orthopaedic practice at two
distinct institutions, one urban and one rural.
Methods: A web-based version of a preference-based quality-of-life
(EQ-5D) and a disease-speciﬁc (KOOS Pain) questionnaire was admin-
istered to all knee patients at two centers over a 9-month period usingtouchscreen devices. Data was analyzed for each institution and the
combined institutions using descriptive statistics.
Results: The methodology for data collection and IT support was found
to require customization to the established workﬂow at each institution
in order to minimize practice disruption. A total of 666 patients were
enrolled between both institutions. Patient compliance was 93% and
95%, respectively. Average questionnaire completion times were 3-5
minutes. Feedback elicited from patients was positive and indicated
patient willingness to participate in the process, and their satisfaction
with the process. Feedback from surgeons indicated that the process
provided helpful clinical information, and was not disruptive to their
clinical workﬂow. Mean EQ-5D and KOOS scores for patients pre- and
post-surgery were consistent with prior literature reports, supporting
the applicability of the outcome data collected for use in routine clinical
practice.
Conclusions: These data demonstrate that validated outcome scores
can be routinely collected as part of standard care, and can contribute to
both patient care and clinical research. Pragmatic clinical data collected
during routine care will become increasingly important for quality
control and comparative effectiveness research in orthopaedic medi-
cine.263
PREDICTIVE FACTORS FOR ONSET OF OA ACCORDING TO THE ACR
CRITERIA IN THE CHECK STUDY
J. Damen y, R. Van Rijn y, P. Emans z, S. Bierma-Zeinstra y. y Erasmus MC,
Rotterdam, The Netherlands; zMaastricht UMC, Maastricht, The
Netherlands
Purpose: In this study we aim to establish how many participants with
pain in hip and/or knee due to early osteoarthritis (OA) develop hip and
knee OA after two years of follow-up according to the ACR (American
college of rheumatism) guidelines. Furthermore we will try to identify
predictive factors for developing such OA.
Methods: We used the prospective CHECK study that included 1002
participants with pain of the knee and/or hip to be due to early
symptomatic OA. Primary outcome of the present study was onset of
hip and/or knee OA according to ACR criteria after 2 years of follow-up.
Predictive factors for onset of evident hip and or knee OA are assessed
with multivariate logistic regression.
Results: Of the participants with hip complaints at baseline 27.6%
(n¼162) and 50.0% (n¼295) were classiﬁed as having hip OA at baseline
according to the ACR clinical criteria and the combined clinical and
radiographic criteria for hip OA respectively. Of the participants with
knee complaints 81.3% (n¼674) and 73.1% (n¼606) participants were
classiﬁed as having knee OA at baseline according to the ACR clinical
criteria and the combined clinical and radiographic criteria for knee OA
respectively.
In the participants with hip complaints who were not classiﬁed as
having hip OA at baseline according to the clinical classiﬁcation criteria
(n¼426), we could analyse all factors in 400 participants after 2 years of
follow up of which 13.6% (n¼58) developed hip OA. For the combined
clinical and radiographic classiﬁcation criteria 295 participants were
classiﬁed with hip OA at baseline, after two years we could asses 264
participants of which 7.4% (n¼21) developed hip OA.
In the group of participants with knee complaints who were not clas-
siﬁed as having knee OA at baseline according to the clinical classiﬁ-
cation criteria (n¼155) we could assess 155 participants after 2 years of
follow up. Of these 33.5% (n¼52) developed knee OA. In the group of
participants with knee complaints 218 participants were classiﬁed as
non-knee OA according to the combined clinical and radiographic
classiﬁcation criteria. We analysed 210 participants after 2 years of
follow up of which 25.2% (n¼55) developed knee OA.
For the ACR clinical classiﬁcation criteria medication use (OR 2.74; 95%
CI 1.42- 5.31) and morning stiffness (OR 2.74; (1.02-3.47) were predic-
tive factors. And for the ACR combined clinical and radiographic clas-
siﬁcation criteria predictive factors were stiffness of the hip (OR 3.16;
95% CI 1.12-8.91), and the presence of Heberden's nodes (OR 10.65; 95%
CI 2.86-39.61). Bilateral complaints were negatively associated with the
occurrence of hip OA (OR 0.18; 95% CI 0.04-0.82).
For the ACR clinical classiﬁcation criteria we could not identify
predictive factors.
For the ACR combined clinical and radiographic classiﬁcation criteriawe
could identify Heberden's nodes as a predictive factor (OR 2.77; 95% CI
1.40-5.49).
